Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
3.620
-0.020 (-0.55%)
Nov 28, 2025, 1:00 PM EST - Market closed
MRVI Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| 192.44 | 259.19 | 288.95 | 883 | 799.24 | 284.1 | Upgrade | |
Revenue Growth (YoY) | -30.47% | -10.30% | -67.28% | 10.48% | 181.32% | 98.48% | Upgrade |
Cost of Revenue | 151.9 | 150.88 | 148.74 | 168.96 | 140.56 | 79.65 | Upgrade |
Gross Profit | 40.54 | 108.31 | 140.2 | 714.04 | 658.68 | 204.45 | Upgrade |
Selling, General & Admin | 154.78 | 161.77 | 147.29 | 125.76 | 100.06 | 94.25 | Upgrade |
Research & Development | 18.18 | 19.22 | 17.28 | 18.37 | 15.22 | 6.42 | Upgrade |
Operating Expenses | 172.95 | 180.99 | 164.57 | 144.13 | 115.28 | 100.67 | Upgrade |
Operating Income | -132.42 | -72.68 | -24.37 | 569.92 | 543.4 | 103.78 | Upgrade |
Interest Expense | -31.7 | -47.7 | -45.89 | -20.41 | -30.26 | -30.74 | Upgrade |
Interest & Investment Income | 15.09 | 27.4 | 27.73 | 2.34 | - | - | Upgrade |
Other Non Operating Income (Expenses) | -4.07 | -2.38 | 667.55 | -4.46 | 6.38 | 0.13 | Upgrade |
EBT Excluding Unusual Items | -153.09 | -95.36 | 625.02 | 547.38 | 519.52 | 73.17 | Upgrade |
Merger & Restructuring Charges | -7.39 | 1.21 | -10.57 | -3.5 | - | - | Upgrade |
Impairment of Goodwill | -54.8 | -166.15 | - | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | 11.25 | 19 | Upgrade |
Other Unusual Items | -2.76 | -1.18 | 3.29 | 7.59 | - | -7.59 | Upgrade |
Pretax Income | -218.04 | -261.48 | 617.74 | 551.47 | 530.77 | 81.7 | Upgrade |
Income Tax Expense | -4.23 | -1.86 | 756.11 | 60.81 | 61.52 | 2.88 | Upgrade |
Earnings From Continuing Operations | -213.81 | -259.62 | -138.38 | 490.66 | 469.25 | 78.82 | Upgrade |
Minority Interest in Earnings | 92.82 | 114.78 | 19.35 | -270.46 | -287.21 | 10.16 | Upgrade |
Net Income | -121 | -144.85 | -119.03 | 220.21 | 182.04 | 88.97 | Upgrade |
Preferred Dividends & Other Adjustments | - | - | - | - | - | 12.08 | Upgrade |
Net Income to Common | -121 | -144.85 | -119.03 | 220.21 | 182.04 | 76.89 | Upgrade |
Net Income Growth | - | - | - | 20.97% | 104.60% | - | Upgrade |
Shares Outstanding (Basic) | 144 | 138 | 132 | 132 | 115 | 10 | Upgrade |
Shares Outstanding (Diluted) | 144 | 138 | 132 | 255 | 258 | 29 | Upgrade |
Shares Change (YoY) | 5.96% | 4.54% | -48.33% | -0.96% | 791.80% | -88.61% | Upgrade |
EPS (Basic) | -0.84 | -1.05 | -0.90 | 1.67 | 1.59 | 7.43 | Upgrade |
EPS (Diluted) | -0.84 | -1.05 | -0.90 | 1.67 | 1.56 | 2.36 | Upgrade |
EPS Growth | - | - | - | 6.97% | -33.73% | - | Upgrade |
Free Cash Flow | -66.33 | -22.19 | 60.67 | 518.89 | 353.72 | 126.78 | Upgrade |
Free Cash Flow Per Share | -0.46 | -0.16 | 0.46 | 2.03 | 1.37 | 4.39 | Upgrade |
Gross Margin | 21.07% | 41.79% | 48.52% | 80.87% | 82.41% | 71.96% | Upgrade |
Operating Margin | -68.81% | -28.04% | -8.43% | 64.54% | 67.99% | 36.53% | Upgrade |
Profit Margin | -62.88% | -55.88% | -41.19% | 24.94% | 22.78% | 27.06% | Upgrade |
Free Cash Flow Margin | -34.47% | -8.56% | 21.00% | 58.76% | 44.26% | 44.63% | Upgrade |
EBITDA | -80.98 | -24.3 | 15.89 | 601.75 | 568.15 | 129.62 | Upgrade |
EBITDA Margin | -42.08% | -9.38% | 5.50% | 68.15% | 71.09% | 45.62% | Upgrade |
D&A For EBITDA | 51.43 | 48.38 | 40.25 | 31.84 | 24.75 | 25.84 | Upgrade |
EBIT | -132.42 | -72.68 | -24.37 | 569.92 | 543.4 | 103.78 | Upgrade |
EBIT Margin | -68.81% | -28.04% | -8.43% | 64.54% | 67.99% | 36.53% | Upgrade |
Effective Tax Rate | - | - | 122.40% | 11.03% | 11.59% | 3.52% | Upgrade |
Advertising Expenses | - | 3.5 | 2.9 | 2.5 | 1.3 | 1.2 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.